<DOC>
	<DOCNO>NCT01589341</DOCNO>
	<brief_summary>This research study chromosomes sample young patient neuroblastoma . Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer .</brief_summary>
	<brief_title>Studying Chromosomes Samples From Younger Patients With Neuroblastoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine impact overall survival patient non-MYCN neuroblastoma 18 month age compare neuroblastoma patient 18 month age . OUTLINE : Archived DNA sample analyze segmental chromosome aberration multiplex ligation-dependent probe amplification ( MLPA ) , polymerase chain reaction ( PCR ) -based technique . The following genomic region study : 1p , 1q , 3p , 4p , 7q , 9p , 11q , 17q , copy number MYCN , NAG , DDX1 , ALK gene .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<criteria>Samples neuroblastoma patient , accord risk stratification , receive cytotoxic treatment never receive chemotherapy complete response ( CR ) OR patient , accord risk stratification , receive cytotoxic treatment initially , localized systemic ( stage Ms M ) relapse without follow chemotherapy Lowrisk Children Oncology Group ( COG ) designation : initial cytotoxic treatment , stage , age , outcome DNA untreated neuroblastoma tumor sample ( patient age group patient age group 1.5 year age ) available COG , Europe , Israel , Japan No MYCN amplification No Schwann cell stromarich tumors No tumor cell content 60 % No DOT No patient diagnose 1997 2005 No lack followup data See Disease Characteristics No initial cytotoxic treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>